Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3017986	s-asveabe	— (—)	74	79	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma, hospital admissions , main diagnosis only

12.65

41.22

1.1

—

Asthma (only as main-diagnosis)

22.11

38.24

1.1

1.0

—

Asthma (only as main-diagnosis), excluding more controls

21.84

37.74

1.1

1.0

—

Asthma (diagnoses ohter than nonallergic)

10.89

35.57

1.1

—

Asthma (mode)

19.97

34.08

1.1

1.0

—

Asthma

19.07

32.24

1.1

1.0

—

Asthma, excluding more controls

18.97

32.06

1.1

1.0

—

Asthma, including avohilmo

8.83

26.13

1.1

—

Chronic lower respiratory diseases

8.68

25.05

1.1

1.0

—

Asthma, unspecified (mode)

25.12

20.08

1.1

1.0

—

Asthma, unspecified (mode), excluding more controls

24.96

20.00

1.1

1.0

—

Asthma, hospital admission 2, infections

14.15

15.58

1.0

—

Asthma-related infections

14.15

15.58

1.0

—

Asthma/COPD (KELA code 203)

6.60

13.96

1.2

1.0

—

15.60

13.82

1.0

—

Asthma-related pneumonia

23.30

10.21

1.0

—

Asthma, hospital admissions 3, pneumonia

23.30

10.21

1.0

—

Asthma-related pneumonia or sepsis

23.30

10.21

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

8.50

10.02

1.0

1.2

—

Obesity related asthma

18.58

8.92

1.0

—

Contact with and exposure to communicable diseases

8.15

8.52

1.1

1.0

—

Persons with potential health hazards related to communicable diseases

7.14

7.88

1.1

1.0

—

Abnormalities of breathing

3.78

7.41

1.1

—

Chronic sinusitis

7.37

6.39

1.1

—

Examination and observation for other reasons

4.23

6.22

1.0

1.2

—

Vasomotor and allergic rhinitis

7.09

5.83

1.0

—

Allergic rhinitis

6.43

5.49

1.0

—

Other and unspecified dermatitis

5.17

5.38

1.0

—

Voice disturbances

10.01

5.02

1.0

—

Dyspnoea

3.14

4.85

1.1

—

Urticaria

6.47

4.76

1.1

1.0

—

Vocal cord dysfunction

11.97

4.76

1.1

1.0

—

Urticaria and erythema

5.72

4.74

1.1

1.0

—

Symptoms and signs involving speech and voice

7.50

4.35

1.0

—

Acute sinusitis

3.39

4.33

1.1

1.0

—

Benign paroxysmal vertigo

11.67

4.27

1.0

—

Oral corticosteroids

2.84

4.26

1.0

1.1

—

Dermatitis

3.83

4.16

1.0

1.1

—

Pollen allergy

5.81

4.08

1.0

—

Allergic asthma (mode)

9.79

3.95

1.0

—

Allergic asthma (mode), excluding more controls

9.79

3.95

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

2.97

3.93

1.1

1.0

—

Triptan medication for migraine, single purchase ok

2.97

3.93

1.1

1.0

—

Triptan medication for migraine, min. 3 purchases

3.05

3.77

1.1

1.0

—

Other arrhythmias

3.14

3.69

1.1

—

Psoriasis

10.00

3.49

1.2

1.0

—

Female infertility, cervical, vaginal, other or unspecified origin

4.11

3.43

1.0

—

Dermatitis and eczema

2.50

3.34

1.0

1.1

—

Excluding asthma or asthma-COPD overlap

4.55

3.02

1.0

—

Other pulmonary diagnosis

4.55

3.02

1.0

—

COPD differential diagnosis

4.55

3.02

1.0

—

ILD differential diagnosis

4.55

3.02

1.0

—

Inflammatory bowel disease treatment related agents

2.40

3.00

1.0

1.1

—

Psoriasis vulgaris

10.00

2.98

1.2

1.0

—

Atopic dermatitis

2.80

2.75

1.0

—

Female infertility

3.52

2.74

1.0

—

Injuries to the neck

5.00

2.72

1.0

—

Dislocation, sprain and strain of joints and ligaments at neck level

6.00

2.69

1.0

—

Sleep apnoea, including avohilmo

2.45

2.63

1.0

1.1

—

Conjunctivitis

2.50

2.61

1.0

—

Papulosquamous disorders

4.67

2.59

1.1

1.0

—

Covid-19 confirmed case

4.67

2.59

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2.92

2.59

1.0

—

Postpartum care and examination

6.34

2.55

1.0

—

Allergic conjunctivitis

2.72

2.51

1.0

—

Disorders of vestibular function (Vertigo)

4.30

2.43

1.0

—

Pulmonary heart disease, diseases of pulmonary circulation

6.25

2.37

1.0

—

Bacterial pneumonia (organism specified)

4.95

2.35

1.2

1.1

—

Persons encountering health services in other circumstances

3.20

2.29

1.2

1.0

—

Cough

3.44

2.23

1.0

1.1

—

Scabies

5.56

2.21

1.2

1.0

—

Peritonsillar abscess

5.56

2.21

1.0

—

Other diseases of upper respiratory tract

2.52

2.20

1.0

1.1

—

Visual disturbances

3.33

2.17

1.1

1.0

—

Other heart diseases, wide

2.21

2.16

1.0

—

Disorders of conjunctiva

2.27

2.15

1.0

1.1

—

Headache

2.41

2.11

1.0

1.1

—

Other joint disorders

2.28

2.09

1.1

—

Visual disturbances and blindness

3.20

2.09

1.1

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

2.14

2.08

1.1

—

Other and unspecified urticaria

5.00

2.07

1.0

—

Spondylosis

2.93

2.04

1.2

1.1

—

Chronic rhinitis, nasopharyngitis and pharyngitis

4.00

2.03

1.0

1.1

—

Meniscus derangement

2.89

1.95

1.0

1.1

—

Migraine with aura and triptan purchases

4.55

1.94

1.0

—

Subjective visual disturbances

4.55

1.94

1.2

1.0

—

Internal derangement of knee

3.17

1.87

1.0

1.1

—

Pediculosis, acariasis and other infestations

4.17

1.82

1.2

1.0

—

Abnormal findings on diagnostic imaging of lung

3.99

1.75

1.6

1.1

—

Bacterial pneumoniae

4.01

1.74

1.2

1.1

—

Car occupant injured in other and unspecified transport accidents

3.85

1.71

1.0

—

Superficial injury of lower leg

3.85

1.71

1.0

—

Influenza and pneumonia

1.96

1.68

1.1

—

Sensorineural hearing loss

2.71

1.67

1.4

1.1

—

Other and unspecified effects of external causes

3.16

1.66

1.0

—

Diseases of inner ear

2.82

1.65

1.0

1.1

—

Cardiac arrhythmias

2.17

1.63

1.0

—

Other benign neoplasms of skin

3.57

1.61

1.2

1.0

—

2.02

1.61

1.0

1.1

—

Fall on same level involving ice and snow

2.50

1.59

1.3

1.1

—

Glaucoma

3.58

1.59

1.0

1.2

—

Arthropathies

2.05

1.57

1.0

1.1

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2.66

1.55

1.0

—

Diseases of salivary glands

3.33

1.52

1.0

—

Pain, not elsewhere classified

3.33

1.52

1.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

2.59

1.51

1.1

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.92

1.51

1.1

—

Fever of other and unknown origin

2.50

1.50

1.0

1.2

—

Venous thromboembolism

2.76

1.44

1.2

1.1

—

Valvular heart disease excluding rheumatic fever

3.28

1.44

1.0

1.2

—

Non-rheumatic valve diseases

3.28

1.43

1.0

1.2

—

Diseases of the respiratory system

3.01

1.43

1.0

—

Chronic diseases of tonsils and adenoids

2.26

1.38

1.0

1.1

—

Mouth breathing

2.94

1.35

1.2

—

Fracture of lower leg, including ankle

0.00

1.34

0.0

1.1

—

First line medication for Crohn's disease

1.84

1.31

1.1

—

1.97

1.30

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.97

1.30

1.1

—

Diseases of male genital organs

3.15

1.30

1.4

1.0

—

Primary gonarthrosis, bilateral

2.85

1.29

1.0

1.2

—

Exposure to unspecified factor

1.83

1.28

1.1

—

Herpesviral [herpes simplex] infections

2.78

1.28

1.0

—

Coxarthrosis, primary

2.82

1.28

1.0

1.2

—

Lumbar disc prolapse

2.13

1.28

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

1.83

1.27

1.1

—

Other reaction to severe stress, and adjustment disorders

2.29

1.26

1.1

1.0

—

Abnormalities of heart beat

2.72

1.25

1.0

1.1

—

All pneumoniae

1.82

1.25

1.1

—

ILD medications

1.81

1.25

1.1

—

Dentofacial anomalies [including malocclusion]

1.93

1.22

1.0

—

Maternal care for other conditions predominantly related to pregnancy

2.35

1.21

1.0

—

Atopic dermatitis, strict definition with reimbursement

2.32

1.19

1.0

—

Transport accidents

2.09

1.16

1.0

1.1

—

Infections of the skin and subcutaneous tissue

2.03

1.14

1.0

1.1

—

General symptoms and signs

1.74

1.11

1.0

1.1

—

Bronchitis

1.75

1.11

1.0

1.1

—

Pain in joint

2.04

1.11

1.1

1.0

—

Other headache syndromes

2.26

1.10

1.0

—

Codes for special purposes

2.25

1.10

1.0

—

Provisional assignment of new diseases of uncertain etiology

2.25

1.10

1.0

—

Concussion

1.98

1.09

1.0

1.1

—

Excessive earwax

2.32

1.06

1.2

1.1

—

Migraine

2.03

1.05

1.0

—

Other intervertebral disc disorders

1.85

1.05

1.1

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.97

1.04

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1.74

1.04

1.1

—

Conductive and sensorineural hearing loss

1.96

1.03

1.3

1.1

—

Diseases of the skin and subcutaneous tissue

1.81

1.02

1.1

—

Anaemias

2.33

1.01

1.0

—

Other obstetric conditions, not elsewhere classified

1.91

1.01

1.0

—

Major coronary heart disease event excluding revascularizations

0.00

1.01

0.0

1.2

—

Angina pectoris

0.00

1.01

0.0

1.2

—

Migraine with aura

2.17

0.98

1.0

—

Disorders of lens

2.34

0.96

1.0

1.3

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.89

0.94

1.1

—

Sleep apnoea

1.77

0.94

1.0

1.1

—

Hypothyroidism, levothyroxine purchases

2.26

0.94

1.0

—

Hypothyroidism and >3 levothyroxin purchases

2.26

0.94

1.0

—

Other maternal disorders predominantly related to pregnancy

1.81

0.92

1.0

—

Hypothyroidism, strict autoimmune

1.81

0.92

1.0

1.1

—

Low back pain

1.79

0.92

1.2

1.0

—

Medical treatment for female infertility

2.13

0.91

1.0

—

Disorders of synovium and tendon

1.95

0.89

1.0

1.1

—

Pneumonia, organism unspecified

1.72

0.88

1.1

—

Diseases of the ear and mastoid process

1.58

0.87

1.2

1.0

—

Other acute lower respiratory infections

1.97

0.85

1.0

—

Acute upper respiratory infections

1.67

0.85

1.0

1.1

—

Diseases of the musculoskeletal system and connective tissue

1.82

0.85

1.0

—

Spondylopathies

1.81

0.83

1.3

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.69

0.83

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

0.00

0.81

0.0

1.0

—

Myocardial infarction

0.00

0.81

0.0

1.2

—

Maternal care for other known or suspected fetal problems

1.90

0.81

1.0

—

Intracranial trauma

1.70

0.80

1.0

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

1.81

0.79

1.0

1.2

—

Unspecified mental disorder

0.00

0.78

0.0

1.0

—

Other soft tissue disorders, not elsewhere classified

1.62

0.77

1.1

—

Coxarthrosis [arthrosis of hip](FG)

2.20

0.76

1.0

1.3

—

Intracranial injury

1.77

0.76

1.0

1.2

—

Senile cataract

2.19

0.76

1.0

1.4

—

Symptoms and signs involving the circulatory and respiratory systems

1.63

0.76

1.0

1.1

—

Gonarthrosis

1.90

0.75

1.0

1.1

—

Benign neoplasms

1.57

0.74

1.1

—

False labour

1.82

0.73

1.0

—

Other specific joint derangements/joint disorders

1.62

0.72

1.1

—

Pain in throat and chest

1.72

0.72

1.1

—

Coxarthrosis

1.94

0.70

1.0

1.2

—

Tonsillectomy and adenotomy

1.57

0.70

1.0

—

Pain in limb

1.63

0.70

1.1

—

Inflammatory diseases of female pelvic organs

1.67

0.69

1.0

—

Dermatophytosis

1.66

0.68

1.1

—

All kidney diseases

0.52

0.68

1.2

1.1

—

Hypothyroidism (congenital or acquired)

1.88

0.68

1.0

—

Obesity due to excess calories

1.63

0.66

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

1.65

0.66

1.0

1.1

—

Any mental disorder

0.56

0.65

1.0

1.1

—

Other disorders of ear

1.60

0.65

1.3

1.0

—

Neurological diseases, wide definition

1.79

0.64

1.0

—

Complications predominantly related to the puerperium

1.72

0.64

1.0

—

Codeine

1.54

0.63

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.72

0.63

1.0

—

Cardiovascular diseases

1.60

0.62

1.0

—

Antenatal screening

0.00

0.62

0.0

1.0

—

Haemorrhage in early pregnancy

1.68

0.62

1.0

—

Excessive attrition of teeth

1.63

0.62

1.3

1.0

—

Malignant neoplasm of breast, HER-positive

0.00

0.61

0.0

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.54

0.61

1.2

1.1

—

Spontaneous abortion

1.59

0.61

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.00

0.61

0.0

1.2

—

Disease of hard tissues of teeth, NOS

1.85

0.61

1.0

1.1

—

Malignant neoplasm of breast, ER-positive, including Hilmo

0.00

0.61

0.0

1.0

—

Endometriosis

1.85

0.60

1.0

—

Intestinal infectious diseases

1.48

0.60

1.1

—

Myocardial infarction, strict

0.00

0.59

0.0

1.2

—

Kela-code for severe mental illness

0.00

0.59

0.0

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.53

0.59

1.3

1.1

—

Inguinal hernia

1.74

0.58

1.2

1.1

—

Cystitis

1.52

0.58

1.1

1.0

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.71

0.57

1.0

1.1

—

Other heart diseases

1.49

0.57

1.0

1.1

—

Dental pulpitis, including avohilmo

1.48

0.57

1.2

1.1

—

Disorders of gallbladder, biliary tract and pancreas

0.54

0.57

1.2

1.1

—

Disorders of the thyroid gland

1.50

0.56

1.0

1.1

—

Any reimbursement code in KELA

1.50

0.55

1.0

—

COPD/asthma/ILD related infections

1.50

0.54

1.0

1.1

—

COPD/asthma related infections

1.50

0.54

1.0

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

0.58

0.54

1.2

1.1

—

Certain infectious and parasitic diseases

1.45

0.53

1.0

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.52

0.52

1.0

1.1

—

Polyarthropathies

1.58

0.50

1.0

1.1

—

Other diseases of urinary system

1.43

0.49

1.2

1.1

—

Hypothyroidism, other/unspecified

1.48

0.49

1.0

1.1

—

Periodontitis

0.61

0.47

1.0

1.1

—

Neurotic, stress-related and somatoform disorders

1.42

0.46

1.1

—

Anxiety disorders

1.42

0.45

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.44

0.45

1.0

1.1

—

Psychiatric diseases

0.63

0.44

1.2

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

0.62

0.44

1.0

—

Paracetamol or NSAID medication

0.00

0.43

0.0

1.0

—

Falls/tendency to fall

1.37

0.43

1.0

1.1

—

Codeine or tramadol medication

1.37

0.43

1.1

—

Diabetic retinopathy, excluding more controls

0.00

0.42

0.0

1.1

—

Maternal care for known or suspected abnormality of pelvic organs

1.55

0.42

1.0

—

Heart failure and coronary heart disease

0.00

0.42

0.0

1.2

—

Unspecified haematuria

0.00

0.41

0.0

1.2

—

Sciatica+with lumbago

1.53

0.41

1.0

1.1

—

Anomalies of dental arch relationship, including avohilmo

0.00

0.41

0.0

1.0

—

Hyperlipidaemia, other/unspecified

0.00

0.41

0.0

1.2

—

Bipolar affective disorders

0.00

0.41

0.0

1.0

—

Other symptoms and signs involving cognitive functions and awareness

0.00

0.41

0.0

1.1

—

Dorsalgia

1.40

0.41

1.2

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1.49

0.41

1.6

1.1

—

Persons encountering health services for specific procedures and health care

0.66

0.40

1.1

—

Autoimmune diseases related-to ILD

1.43

0.40

1.2

1.1

—

Recurrent or chronic depression

1.46

0.40

1.0

—

Medicines for HER+ breast cancer

0.00

0.40

0.0

1.0

—

Nonsuppurative otitis media

0.00

0.40

0.0

1.0

—

Unstable angina pectoris

0.00

0.40

0.0

1.2

—

Schizophrenia or delusion

0.00

0.40

0.0

1.0

—

Schizophrenia, schizotypal and delusional disorders

0.00

0.40

0.0

1.0

—

Schizophrenia or delusion, excluding more controls

0.00

0.39

0.0

1.1

—

Complications of procedures, not elsewhere classified

1.38

0.38

1.1

—

Other diseases of intestines

0.70

0.38

1.0

1.1

—

Postpartum hemorraghe, all women as controls

1.41

0.38

1.0

—

Disorders of sclera, cornea, iris and ciliary body

1.39

0.38

1.0

—

Disorders of skin appendages

1.39

0.38

1.0

—

Pre-eclampsia or poor fetal growth

1.38

0.38

1.0

—

Reimbursement for rheumatic diseases

1.38

0.38

1.0

—

Malignant neoplasm, wide definition for exclusion

0.62

0.37

1.2

1.0

—

Other dorsopathies, not elsewhere classified

1.36

0.36

1.1

1.0

—

Cholelithiasis, broad definition with cholecystitis

0.63

0.36

1.2

1.1

—

Mycoses

1.38

0.35

1.1

—

Viral infections characterized by skin and mucous membrane lesions

1.38

0.35

1.0

1.1

—

Other anxiety disorders

1.37

0.34

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1.35

0.34

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.34

0.34

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

0.66

0.33

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases

1.34

0.33

1.1

—

Temporomandibular joint disorders, including avohilmo

1.31

0.33

1.0

—

Hernia

1.37

0.32

1.1

—

Certain infectious and parasitic diseases

0.72

0.32

1.0

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.36

0.32

1.0

1.2

—

Gingivitis and periodontal diseases

0.68

0.32

1.1

—

Injuries to the elbow and forearm

1.37

0.31

1.0

—

Gastro-oesophageal reflux disease

1.34

0.31

1.0

1.1

—

Gonarthrosis,primary

1.27

0.30

1.0

1.1

—

Neurological diseases

1.36

0.30

1.0

1.1

—

Complications of medical and surgical care

1.24

0.29

1.0

1.1

—

Episodal and paroxysmal disorders

1.30

0.28

1.0

1.1

—

Other nutritional deficiencies

1.30

0.28

1.0

1.1

—

Finngen Rheumatological endpoints

1.29

0.27

1.1

—

Exposure to other specified factors

1.22

0.27

1.1

—

Soft tissue disorders

1.29

0.27

1.0

1.1

—

Cholelithiasis

0.69

0.26

1.2

1.0

—

Parasetamol

1.27

0.26

1.0

1.1

—

Antihypertensive medication - note that there are other indications

1.33

0.26

1.0

1.1

—

Accidents

1.22

0.26

1.0

1.1

—

Other external causes of accidental injury

1.22

0.26

1.0

1.1

—

Postpartum haemorrhage

1.32

0.23

1.0

—

Noninflammatory disorders of female genital tract

1.25

0.23

1.0

—

L04AX Other immunosuppressants

1.28

0.23

1.0

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.26

0.22

1.0

1.1

—

Second line medication for Crohn's disease

1.22

0.22

1.0

—

Fenamates

0.00

0.22

0.0

1.0

—

Hypertensive heart and/or renal disease

0.00

0.22

0.0

1.3

—

Hypertensive Heart Disease

0.00

0.22

0.0

1.3

—

Glucosamine medication

0.00

0.21

0.0

1.0

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.00

0.21

0.0

1.1

—

Malignant neoplasm of digestive organs

0.00

0.21

0.0

1.0

—

Autoimmune diseases

1.25

0.21

1.1

—

Continuous positive airway pressure

0.00

0.21

0.0

1.1

—

Sequelae of cerebrovascular disease

0.00

0.21

0.0

1.0

—

Myocardial infarction, without ST-elevation

0.00

0.21

0.0

1.2

—

Eating disorders

0.00

0.21

0.0

1.0

—

Retained placenta and membranes, without haemorrhage

0.00

0.21

0.0

1.0

—

Obstructed labour due to maternal pelvic abnormality

0.00

0.21

0.0

1.0

—

Biological medication for rheuma

0.00

0.21

0.0

1.0

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

0.00

0.21

0.0

1.0

—

Stomatitis and related lesions

0.00

0.21

0.0

1.0

—

Combinations of oral blood glucose lowering drugs

0.00

0.21

0.0

1.2

—

Other septicaemia

0.00

0.21

0.0

1.1

—

Postpartum hemorraghe, parous women as controls

1.18

0.21

1.0

—

Haemorrhage from respiratory passages

0.00

0.21

0.0

1.2

—

Other and unspecified nonorganic psychotic disorders

0.00

0.21

0.0

1.0

—

Tooth eruption problems

0.00

0.21

0.0

1.0

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1.30

0.21

1.0

—

Septicaemia

0.00

0.21

0.0

1.2

—

Arthrosis

1.27

0.21

1.0

1.1

—

Oxycodone

0.00

0.21

0.0

1.2

—

Inflammatory bowel disease, strict (require KELA)

0.00

0.21

0.0

1.0

—

IBD patients in KELA-register

0.00

0.21

0.0

1.0

—

Depression

1.24

0.20

1.0

1.1

—

Disorders of breast

1.27

0.20

1.0

—

Localized swelling, mass and lump of skin and subcutaneous tissue

0.00

0.20

0.0

1.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.13

0.18

1.0

—

Gonarthrosis [arthrosis of knee](FG)

1.20

0.18

1.0

1.1

—

Irregular menses

1.20

0.18

1.0

—

Benzodiazepine use

1.22

0.18

1.2

1.0

—

Dislocation, sprain and strain of joints and ligaments of knee

1.19

0.18

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.17

0.18

1.1

—

Obesity

1.16

0.17

1.0

1.1

—

Obesity and other hyperalimentation

1.16

0.17

1.0

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

0.75

0.17

1.2

1.1

—

Disorders of eyelid, lacrimal system and orbit

0.74

0.17

1.4

1.1

—

Anxiety disorders, excluding more controls

1.23

0.17

1.1

—

Appendicitis, broad definition

0.72

0.17

1.0

1.1

—

Diseases of appendix

0.72

0.17

1.0

1.1

—

Opioids

1.22

0.16

1.0

1.1

—

Dorsopathies

1.22

0.16

1.1

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

0.77

0.16

1.2

1.1

—

Diseases of the eye and adnexa

1.16

0.16

1.0

1.1

—

Fall on same level

1.18

0.16

1.1

—

Insomnia

1.15

0.15

1.1

1.0

—

Sleep disorders

1.14

0.15

1.1

1.0

—

Sleep disorders (combined)

1.20

0.15

1.1

—

Any gastric operation

0.78

0.15

1.0

—

GASTRO-related operations

0.78

0.15

1.0

—

Hypertension

0.81

0.15

1.0

1.1

—

Hypertensive diseases

0.81

0.15

1.0

1.1

—

Type 2 diabetes

0.81

0.14

1.1

—

Persons encountering health services in other circumstances, wide

0.83

0.13

1.2

1.1

—

Chronic apical periodontitis

1.16

0.12

1.1

—

Lower back pain or/and sciatica

1.16

0.11

1.2

1.0

—

Complications of surgical and medical care, not elsewhere classified

1.16

0.10

1.1

—

Rotator cuff syndrome

1.12

0.10

1.4

1.1

—

ILD medications: immunosuppressive drugs

1.11

0.09

1.0

1.1

—

Diabetes mellitus in pregnancy

1.07

0.09

1.0

—

Diseases of middle ear and mastoid

1.08

0.09

1.0

—

Other abnormal products of conception

1.03

0.09

1.0

—

Carpal tunnel syndrome

1.02

0.09

1.0

1.1

—

Injury, poisoning and certain other consequences of external causes

1.07

0.09

1.0

1.1

—

Gestational diabetes (for exclusion)

1.04

0.08

1.0

—

Medical abortion

0.77

0.08

1.0

—

Artificial joint operation, meniscal resection

0.79

0.08

1.0

1.1

—

Injuries to the shoulder and upper arm

0.79

0.08

1.4

1.1

—

Tramadol

1.10

0.08

1.1

—

Constipation

1.08

0.08

1.0

1.1

—

Pregnancy with abortive outcome

1.04

0.08

1.0

—

All anxiety disorders

1.04

0.08

1.0

—

Injuries to the ankle and foot

1.04

0.08

1.0

1.1

—

Anxiety (asthma-related co-morbidities)

1.02

0.08

1.0

—

Neoplasms

1.06

0.07

1.0

—

Abdominal and pelvic pain

1.03

0.07

1.1

—

Symptoms and signs involving the digestive system and abdomen

1.03

0.07

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

0.87

0.07

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.08

0.07

1.1

—

Intestinal infectious diseases

1.07

0.07

1.1

—

Any event in cancer register

1.13

0.07

1.2

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

0.85

0.07

1.1

—

Diabetes medication

0.87

0.06

1.1

—

Injuries to the knee and lower leg

1.11

0.06

1.0

1.1

—

Use of hypnotics and sedatives

1.11

0.05

1.1

—

Injuries to the wrist and hand

1.10

0.04

1.0

1.1

—

Mood [affective] disorders

1.08

0.02

1.0

1.1

—

Mood disorders

1.08

0.02

1.0

1.1

—

Used for control exclusion in common control thyroid runs

1.03

0.00

1.0

1.1

—

Nerve, nerve root and plexus disorders

1.02

0.00

1.0

1.1

—

Injuries to the head

0.98

0.00

1.0

1.1

—

Diabetes, varying definitions

0.96

0.00

1.1

—

Diabetes mellitus

0.96

0.00

1.1

—

L02BA Anti-estrogens

0.00

0.0

1.0

—

Intestinal stricture

0.00

0.0

1.0

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

0.00

0.0

1.0

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

0.00

0.0

1.0

—

Bell's palsy

0.00

0.0

1.0

—

Endocrine, nutritional and metabolic diseases

0.90

0.00

1.0

1.1

—

Other congenital malformations

0.00

0.0

1.0

—

Alcohol dependence

0.00

0.0

1.1

—

Status post-ami

0.00

0.0

1.1

—

Enlarged lymph nodes

0.00

0.0

1.0

—

Colorectal adenocarcinoma

0.00

0.0

1.0

—

Calcific tendinitis of shoulder

0.00

0.0

1.0

—

Other diseases of intestine

0.00

0.0

1.0

—

Other blood glucose lowering drugs, excl. Insulins

0.00

0.0

1.0

—

Budesonide

0.00

0.0

1.0

—

Plantar fascial fibromatosis

0.00

0.0

1.0

—

Problems related to lifestyle

0.00

0.0

1.0

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

0.00

0.0

1.0

—

Ulcerative colitis (strict definition, require KELA)

0.00

0.0

1.0

—

DVT of lower extremities

0.00

0.0

1.0

—

Other sexually transmitted chlamydial diseases

0.00

0.0

1.0

—

Alzheimer’s disease, strict definition

0.00

0.0

1.0

—

Diabetic nephropathy, excluding more controls

0.00

0.0

1.1

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.0

1.0

—

Benign mammary dysplasia

0.00

0.0

1.0

—

Malignant neoplasm

0.90

0.00

1.3

1.0

—

Focal epilepsy, strict definition

0.00

0.0

1.0

—

Fibroblastic disorders

0.00

0.0

1.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

0.97

0.00

1.0

—

Follow-up examination after treatment for malignant neoplasms

0.00

-0.00

0.0

1.0

—

Other gastritis (incl. Duodenitis)

0.00

-0.00

0.0

1.0

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Eating disorder

0.00

-0.00

0.0

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

0.00

-0.00

0.0

1.0

—

Abnormal findings on diagnostic imaging of other body structures

0.00

-0.00

0.0

1.0

—

Type 2 diabetes, strict (exclude DM1)

0.96

-0.00

1.1

—

Effects of foreign body entering through natural orifice

0.00

-0.00

0.0

1.1

—

Hypertensive diseases (excluding secondary)

1.02

-0.00

1.0

1.1

—

Maternal care for known or suspected disproportion

0.00

-0.00

0.0

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

0.93

-0.00

1.0

—

Acute and transient psychotic disorders

0.00

-0.00

0.0

1.0

—

Disorders of continuity of bone

0.00

-0.00

0.0

1.0

—

Other sexually transmitted chlamydial diseases

0.00

-0.00

0.0

1.0

—

Mood disorders, excluding more controls

1.01

-0.00

1.0

1.1

—

Speech therapy

0.00

-0.00

0.0

1.0

—

Medical observation and evaluation for suspected diseases and conditions

0.98

-0.00

1.0

1.2

—

Type 2 diabetes, definitions combined

0.98

-0.00

1.1

—

Family history of malignant neoplasm

0.00

-0.00

0.0

1.0

—

Lichen sclerosus et atrophicus

0.00

-0.00

0.0

1.0

—

Sarcoidosis

0.00

-0.00

0.0

1.0

—

Diabetic nephropathy

0.00

-0.00

0.0

1.2

—

Misadventures to patients during surgical and medical care

0.00

-0.00

0.0

1.0

—

Paralytic ileus and intestinal obstruction

0.00

-0.00

0.0

1.0

—

External causes of morbidity and mortality

0.97

-0.00

1.0

1.1

—

Superficial injury of ankle and foot

0.00

-0.00

0.0

1.0

—

Endometriosis of rectovaginal septum and vagina

0.00

-0.00

0.0

1.0

—

Sulfonylureas

0.00

-0.00

0.0

1.1

—

Other disorders of urethra and urinary system

0.84

-0.00

1.2

1.0

—

Fracture of skull and facial bones

0.00

-0.00

0.0

1.0

—

Unspecified lump in breast

0.00

-0.00

0.0

1.0

—

Impingement syndrome of shoulder

0.00

-0.00

0.0

1.1

—

Gout

0.00

-0.00

0.0

1.3

—

Adenomyosis (Endometriosis of uterus)

0.00

-0.00

0.0

1.0

—

Sequelae of injuries of lower limb

0.00

-0.00

0.0

1.0

—

Heartburn

0.00

-0.00

0.0

1.0

—

Other obstetric trauma

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of corpus uteri, including Hilmo

0.00

-0.00

0.0

1.0

—

Dizziness and giddiness

0.97

-0.00

1.0

1.1

—

N06DA Anticholinesterases

0.00

-0.00

0.0

1.0

—

Selective serotonin reuptake inhibitors

1.02

-0.00

1.0

1.1

—

Tumor necrosis factor alpha inhibitors

0.00

-0.00

0.0

1.0

—

Nonalcoholic fatty liver disease

0.00

-0.00

0.0

1.0

—

5-aminosalicylic acid

0.00

-0.00

0.0

1.0

—

Abnormal involuntary movements

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of colon, including Hilmo

0.00

-0.00

0.0

1.0

—

Substance use, excluding alcohol

0.00

-0.00

0.0

1.0

—

Colorectal cancer

0.00

-0.00

0.0

1.0

—

malignant neoplasm of female genital organs

0.00

-0.00

0.0

1.0

—

L02BG Aromatase inhibitors

0.00

-0.00

0.0

1.0

—

Use of pramipexole

0.00

-0.00

0.0

1.0

—

Colectomy operation

0.00

-0.00

0.0

1.0

—

Congenital malformations of genital organs

0.00

-0.00

0.0

1.0

—

Other antidepressants

1.00

-0.00

1.0

1.1

—

Cardiomyopathy

0.00

-0.00

0.0

1.0

—

Glomerular diseases

0.00

-0.00

0.0

1.0

—

Acne

0.00

-0.00

0.0

1.0

—

Salpingitis and oophoritis

0.00

-0.00

0.0

1.0

—

Other obstructed labour

0.00

-0.00

0.0

1.0

—

Inflammatory disease of cervix uteri

0.00

-0.00

0.0

1.0

—

Spontaneous rupture of synovium and tendon

0.00

-0.00

0.0

1.0

—

Metatarsalgia

0.00

-0.00

0.0

1.0

—

Aneurysms, operations, SAH

0.00

-0.00

0.0

1.0

—

Aortic aneurysm

0.00

-0.00

0.0

1.0

—

Acne vulgaris

0.00

-0.00

0.0

1.0

—

Any dementia

0.00

-0.00

0.0

1.0

—

Embedded teeth, including avohilmo

0.00

-0.00

0.0

1.0

—

Shoulder lesions

0.98

-0.00

1.3

1.1

—

Artrosis, including avohilmo

1.01

-0.00

1.0

1.1

—

Deep endometriosis

0.00

-0.00

0.0

1.0

—

Diseases of oesophagus, stomach and duodenum

0.93

-0.00

1.0

1.1

—

Recurrent aphthous stomatitis , including avohilmo

0.00

-0.00

0.0

1.0

—

Zoster [herpes zoster]

0.00

-0.00

0.0

1.0

—

Gastrointestinal diseases

0.88

-0.00

1.0

—

Insulin, fast-acting (human)

0.00

-0.00

0.0

1.0

—

KRA_PSY_EATING, excluding more controls

0.00

-0.00

0.0

1.0

—

Caries of enamel

0.92

-0.00

1.1

—

Solid cancers, helper endpoint

0.90

-0.00

1.3

1.0

—

Benign neoplasm: Sigmoid colon

0.00

-0.00

0.0

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

0.00

-0.00

0.0

1.0

—

Other inflammation of eyelid

0.00

-0.00

0.0

1.0

—

Any dementia, excluding more controls

0.00

-0.00

0.0

1.0

—

Metabolic disorders

0.92

-0.00

1.1

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

0.00

-0.00

0.0

1.0

—

Other diseases of the digestive system

0.00

-0.00

0.0

1.0

—

Gout, FINNGEN

0.00

-0.00

0.0

1.1

—

Other diseases of liver

0.00

-0.00

0.0

1.0

—

Alzheimer disease, including avohilmo

0.00

-0.00

0.0

1.0

—

Gout, idiopatic and unspecified

0.00

-0.00

0.0

1.2

—

Polycystic ovarian syndrome, consortium definition

1.01

-0.00

1.0

—

Pregnancy hypertension

0.97

-0.00

1.0

—

Carcinoma in situ of breast, intraductal

0.00

-0.00

0.0

1.0

—

Schizophrenia

0.00

-0.00

0.0

1.0

—

Leiomyoma of uterus

0.97

-0.00

1.0

—

Other (not insulin) diabetes medications

0.97

-0.00

1.1

—

Blepharochalasis

0.00

-0.00

0.0

1.0

—

Alzheimer disease

0.00

-0.00

0.0

1.0

—

Chalazion

0.00

-0.00

0.0

1.0

—

Focal epilepsy

0.00

-0.00

0.0

1.0

—

Iron deficiency anaemia secondary to blood loss (chronic)

0.00

-0.00

0.0

1.0

—

Coronary artery bypass grafting

0.00

-0.00

0.0

1.3

—

Other or unspecified ileus, impaction or obstruction

0.00

-0.00

0.0

1.0

—

Implicit Sepsis

0.85

-0.00

1.2

1.1

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

0.00

-0.00

0.0

1.0

—

Biguanides

1.02

-0.00

1.1

—

Hypertension, essential

0.92

-0.00

1.0

1.1

—

Seborrhoeic keratosis

0.00

-0.00

0.0

1.0

—

Other embolism and thrombosis

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of colon

0.00

-0.00

0.0

1.0

—

Other viral diseases, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Cholecystectomy

0.96

-0.00

1.2

1.0

—

Use of anticholinesterases

0.00

-0.00

0.0

1.0

—

Hypo-osmolality and hyponatraemia

0.00

-0.00

0.0

1.0

—

Osteoporosis

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Aspergillus versicolor IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS